by Clinical Neuropsychologist Online | Wednesday, April 2, 2025 | Dementia
Abstract INTRODUCTION TRAILBLAZER-ALZ 6 (NCT05738486) is a multicenter, double-blind, ongoing phase 3b study in early symptomatic Alzheimer’s disease. METHODS Participants (n = 843) were randomized 1:1:1:1 (standard + three alternative donanemab dosing arms)....
by Clinical Neuropsychologist Online | Wednesday, April 2, 2025 | Neurorehabilitation
Neurorehabilitation and Neural Repair, Ahead of Print. BackgroundThe Wolf Motor Function Test (WMFT) and its modified versions are widely used to assess upper limb (UL) function in stroke survivors. However, comprehensive evaluations of its psychometric properties are...
by Clinical Neuropsychologist Online | Wednesday, April 2, 2025 | Dementia
Dementia, Ahead of Print. IntroductionCurrent support programs for individuals with dementia focus primarily on patients living with caregivers. Research on individuals with dementia living alone is sparse, with small sample sizes. This report describes data collected...
by Clinical Neuropsychologist Online | Wednesday, April 2, 2025 | Neuroscience
Nature Neuroscience, Published online: 02 April 2025; doi:10.1038/s41593-025-01950-1Author Correction: An activity-regulated transcriptional program directly drives synaptogenesis If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content...
by Clinical Neuropsychologist Online | Wednesday, April 2, 2025 | Neuroscience
Nature Neuroscience, Published online: 02 April 2025; doi:10.1038/s41593-025-01912-7The authors uncover slow, facilitating inhibitory connections between serotonin neurons in the dorsal raphe, refuting autoinhibition theories. This recurrence drives winner-take-all...
